Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?
Background: Despite an existing safe and effective vaccine for hepatitis B virus (HBV), it is still a major public health concern. Nowadays, several drugs are used to treat chronic hepatitis B; however, full healing remains controversial. The viral covalently closed circular DNA (cccDNA) formed by H...
Saved in:
| Main Authors: | Giovana Paula Angelice, Pedro Henrique Roque, Gabriel Valente, Krishna Galvão, Livia Melo Villar, Vinicius Motta Mello, Francisco C. A. Mello, Bárbara Vieira Lago |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/16/11/1710 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
by: Suxian Zhao, et al.
Published: (2025-01-01) -
Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
by: Wei He, et al.
Published: (2024-12-01) -
Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA
by: Jihua Ren, et al.
Published: (2025-01-01) -
Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy
by: Kongying Hu, et al.
Published: (2024-12-01) -
Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA
by: Deok-Hwa Seo, et al.
Published: (2024-12-01)